Steven Cohen's IMUX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 10,806 shares of Immunic, Inc. (IMUX) worth $166,088, representing 0.00% of the portfolio. First purchased in 2020-Q2, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in IMUX, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2021, adding 62,500 shares. Largest reduction occurred in Q2 2023, reducing 71,466 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Immunic (IMUX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Immunic (IMUX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +10,806 | New Buy | 10,806 | $15.37 |
| Q2 2023 | -71,466 | Sold Out | 0 | $0.00 |
| Q4 2022 | -61,034 | Reduce 46.06% | 71,466 | $14.00 |
| Q2 2022 | +60,000 | Add 82.76% | 132,500 | $34.70 |
| Q4 2021 | +10,000 | Add 16.00% | 72,500 | $95.70 |
| Q3 2021 | +62,500 | New Buy | 62,500 | $88.50 |
| Q2 2021 | -43,305 | Sold Out | 0 | $0.00 |
| Q1 2021 | +22,855 | Add 111.76% | 43,305 | $159.40 |
| Q4 2020 | +20,450 | New Buy | 20,450 | $152.91 |
| Q3 2020 | -17,500 | Sold Out | 0 | $0.00 |
| Q2 2020 | +17,500 | New Buy | 17,500 | $121.20 |
Steven Cohen's Immunic Investment FAQs
Steven Cohen first purchased Immunic, Inc. (IMUX) in Q2 2020, acquiring 17,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Immunic, Inc. (IMUX) for 14 quarters since Q2 2020.
Steven Cohen's largest addition to Immunic, Inc. (IMUX) was in Q3 2021, adding 62,500 shares worth $5.53 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 10,806 shares of Immunic, Inc. (IMUX), valued at approximately $166,088.
As of the Q2 2026 filing, Immunic, Inc. (IMUX) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Immunic, Inc. (IMUX) was 132,500 shares, as reported at the end of Q2 2022.